Brandinium

Trademark search for:

GLENMARK GENERICS LTD.

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2008-02-20 — Application filed
  • 2008-02-26 — Application filed
  • 2008-02-27 — Notice of pseudo mark mailed
  • 2008-06-02 — Final disposition recorded
  • 2008-06-02 — Final disposition recorded
  • 2008-06-02 — Assigned to examiner
  • 2008-06-02 — Final disposition recorded
  • 2008-12-01 — Office action issued
  • 2008-12-15 — Teas/email correspondence entered
  • 2008-12-15 — Assigned to lie
  • 2008-12-15 — Correspondence received in law office
  • 2008-12-16 — Approved for pub - principal register
  • 2008-12-22 — Law office publication review completed
  • 2009-01-07 — Notice of publication
  • 2009-01-27 — Published for opposition
  • 2009-04-21 — Noa mailed - sou required from applicant
  • 2009-10-21 — Sou extension 1 filed
  • 2009-11-23 — Application abandoned
  • 2009-11-23 — Application abandoned
  • 2009-12-01 — Sou extension received with teas petition
  • 2009-12-01 — Petition to revive-received
  • 2009-12-01 — Petition to revive-granted
  • 2009-12-01 — Teas petition to revive received
  • 2010-02-01 — Case assigned to intent to use paralegal
  • 2010-02-02 — Assigned to petition staff
  • 2010-02-03 — Incomplete petition notice mailed
  • 2010-02-24 — Petition granted - extension request filed
  • 2010-03-01 — Sou extension 1 granted
  • 2010-04-21 — Sou extension 2 filed
  • 2010-05-19 — Sou extension received with teas petition
  • 2010-05-19 — Petition to revive-granted
  • 2010-05-19 — Teas petition to revive received
  • 2010-05-20 — Sou extension 2 granted
  • 2010-05-21 — Notice of approval of extension request e-mailed
  • 2010-10-21 — Sou extension 3 filed
  • 2010-10-26 — Sou extension received with teas petition
  • 2010-10-26 — Petition to revive-granted
  • 2010-10-26 — Teas petition to revive received
  • 2010-10-27 — Sou extension 3 granted
  • 2010-10-28 — Notice of approval of extension request e-mailed
  • 2011-04-21 — Sou extension 4 filed
  • 2011-05-23 — Application abandoned
  • 2011-05-23 — Application abandoned
  • 2011-06-07 — Teas statement of use received
  • 2011-06-07 — Use amendment filed
  • 2011-06-07 — Sou extension received with teas petition
  • 2011-06-07 — Petition to revive-granted
  • 2011-06-07 — Teas petition to revive received
  • 2011-06-09 — Statement of use processing complete
  • 2011-06-09 — Sou extension 4 granted
  • 2011-06-10 — Allowed principal register - sou accepted
  • 2011-06-10 — Notice of approval of extension request e-mailed
  • 2011-06-15 — Law office registration review completed
  • 2011-06-16 — Notice of acceptance of statement of use e-mailed
  • 2011-07-19 — Registered-principal register
  • 2017-07-14 — Teas section 8 received
  • 2017-08-23 — Case assigned to post registration paralegal
  • 2017-09-02 — Registered - sec. 8 (6-yr) accepted
  • 2017-09-02 — Notice of acceptance of sec. 8 - e-mailed
  • 2020-07-19 — Courtesy reminder - sec. 8 (10-yr)/sec. 9 e-mailed
  • 2022-01-21 — Cancelled sec. 8 (10-yr)/expired section 9
  • 2022-01-21 — Final status recorded

Owner Information

GLENMARK GENERICS INC., USA
MAHWAH , NJ
GLENMARK GENERICS INC., USA
MAHWAH , NJ
Glenmark Pharmaceuticals Inc., USA
Mahwah , NJ
Glenmark Pharmaceuticals Inc., USA
Mahwah , NJ

Correspondent

Hany W. Rizkalla GLENMARK PHARMACEUTICALS INC., USA
750 Corporate Dr.
Legal Department
MAHWAH, NJ 07430

Filing Details

Filing Date:
2008-02-20
Status Date:
2022-01-21
Category:
Pharmaceuticals
Filing Year:
2008

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.